Compared with RSL3 monotreatment group, there were 86 miRNAs displaying >2-fold change and 70 miRNAs displaying <0.5-fold change in the RSL3 combined with IFN-γ treatment group, delineating the specific expression profile of miRNAs in IFN-γ-driven ferroptosis in melanoma cell (online supplemental figure S1D, online supplemental table S1). The gene discussed is IFNG; the disease is melanoma.